Elanco Animal Health (NYSE:ELAN) Releases FY 2026 Earnings Guidance

Elanco (ELAN) Q3 2026 Earnings Call Transcript

Elanco beat expectations and raised guidance on strong innovation sales.

Elanco Animal Health (NYSE:ELAN) Releases FY 2026 Earnings Guidance

Elanco Animal Health (NYSE:ELAN) updated its FY 2026 earnings guidance. The company provided EPS guidance of 1.170-1.200 for the period, compared to the consensus estimate of 1.130. The company also issued revenue guidance of $5.2 billion, compared to the consensus estimate of $5.1 billion.

Elanco (NYSE: ELAN) raises full-year outlook and hits a debt milestone early

What happened Elanco Animal Health Incorporated (NYSE: ELAN) raised full-year 2026 guidance after third-quarter revenue rose 11% to $1.26 billion. Organic constant currency growth was 9%. That measure strips out foreign exchange, the April 2026 AHV International acquisition and royalty revenue sold to a third party. The company now expects full-year revenue of $5.16 billion […]

Elanco Animal Health Sees Strong Momentum Heading Into 2027

Elanco Animal Health beats Q3 earnings and revenue estimates, driven by Pet Health demand and pricing gains, while raising its full-year 2026 outlook.